Methods | RCT, parallel‐group design Method of randomisation: stratified randomisation, generation of random sequence not stated Allocation concealment: not described Blinding of outcome assessors: unclear Adverse events: none Deaths: none Drop outs: 5 (2 in EXP group, 3 in CTL group) ITT: no |
|
Participants | Country: China 50 participants (25 in EXP group, 25 in CTL group) Ambulatory at study onset: yes (FAC ≥ 3) Mean age: 55 years (CTL and EXP group) Inclusion criteria: comply with the Fourth National Stroke diagnostic criteria; stable disease, blood pressure and heart rate control in the normal range, lower extremity Brunnstrom stage ≥ 2, lower extremity limb paralysis without severe clonus and joint stiffness (Ashworth scale ≤ 2),patients being able to walk more than 10 metres independently or under supervision and without the help of assistive devices, walking speed ≥ 0.17 m/s Exclusion criteria: history of myocardial infarction, severe ventricular arrhythmias, chronic heart failure; lower extremity total joint replacement or severe arthritis, recurrent stroke, other severe conditions |
|
Interventions | 2 arms, treated as inpatients:
|
|
Outcomes | Outcomes were assessed at baseline and at the end of the intervention phase:
|
|
Notes | ||
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Unclear risk | Not described |
Allocation concealment (selection bias) | Unclear risk | Not described |
Blinding of outcome assessment (detection bias) All outcomes | Unclear risk | Not described |